Eneda Toska, Ph.D. (Johns Hopkins) – Hybrid Epigenetics Monthly Seminar Series
May 9 @ 4:00 pm - 5:00 pm
Eneda Toska, Ph.D.
Assistant Professor of Oncology
Johns Hopkins School of Medicine
The Toska Lab
Dr. Toska joined the Kimmel Cancer Center as an Assistant Professor of Oncology in the Cancer Invasion and Metastasis Program (CIM), in close collaboration with the Women’s Malignancies Disease Group. She also was appointed to a secondary faculty position in the Bloomberg School of Public Health Department of Biochemistry and Molecular Biology (BMB), with membership in the BMB Ph.D. program.
Dr. Toska graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester; received her master’s degree from the University at Buffalo, magna cum laude; and earned her doctorate from the University at Buffalo, summa cum laude; completing her postdoctoral work with Dr. Jose Baselga at Memorial Sloan Kettering (MSK) and after a senior research scientist role with Dr. Maurizio Scaltriti at MSK. Dr. Toska has been awarded the Breast Cancer Research Alliance Young Investigator Award, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, a K22 Transition to Independence Award, a grant from the Innovation in Cancer Informatics, and has been selected as a 2021 AACR NextGen Star.
The Toska Lab’s research focus is centered on elucidating the role that transcriptional and epigenetic regulators play in normal and cancer development, and therapeutic response. They are passionate about asking clinically relevant questions and translating basic laboratory findings into therapeutic applications to benefit cancer patients while at the same time providing new insights into the fundamental mechanisms of how epigenetic regulators regulate transcription and dictate cell identity. To achieve these goals, the Toska lab aims to undertake a multidisciplinary approach integrating biochemistry, cell signaling, genomics, and epigenomics at bulk and single-cell level, organoid technology, and mouse genetics to study the fundamental processes by which epigenetic regulators regulate transcription, cross-talk with signaling pathways, and have the ability to drive transformation and dictate therapeutic response in nuclear receptor-dependent cancers.
Hosted by Liling Wang, Ph.D.